Multiple Ascending Dose and DDI Study

NCT03031119 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
62
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer